Cargando…
More Accessible COVID-19 Treatment Through Monoclonal Antibody Infusion in the Emergency Department
INTRODUCTION: Monoclonal antibody (MAB) infusion is the first treatment to manage coronavirus 2019 (COVID-19) in an outpatient setting. Yet increased risk of severe COVID-19 illness may occur from inequities in social determinants of health including access to quality healthcare. Given the safety-ne...
Autores principales: | Heinert, Sara W., McCoy, Jonathan, Strickland, Pamela Ohman, Riggs, Renee, Eisenstein, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Department of Emergency Medicine, University of California, Irvine School of Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541995/ https://www.ncbi.nlm.nih.gov/pubmed/36205670 http://dx.doi.org/10.5811/westjem.2022.5.55234 |
Ejemplares similares
-
Emergency Department Access During COVID-19: Disparities in Utilization by Race/Ethnicity, Insurance, and Income
por: Lowe, Jason, et al.
Publicado: (2021) -
COVID-19: An Emerging Threat to Antibiotic Stewardship in the Emergency Department
por: Pulia, Michael S., et al.
Publicado: (2020) -
Underutilization of the Emergency Department During the COVID-19 Pandemic
por: Lucero, Anthony D., et al.
Publicado: (2020) -
Strategies in Emergency Department-based COVID-19 Vaccination
por: Chary, Anita, et al.
Publicado: (2022) -
Gender Differences in CDC Guideline Compliance for STIs in Emergency Departments
por: Kane, Bryan G., et al.
Publicado: (2017)